Study: NCT05460364

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR1018-1
Description: Treatment group A : One tablet of BR1018-1 administered alone once daily for 9 days.~Treatment group C : One tablet each of BR1018-1 and BR1018-2 administered in combination once daily for 9 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR1018-1
Description: Treatment group A : One tablet of BR1018-1 administered alone once daily for 9 days.~Treatment group C : One tablet each of BR1018-1 and BR1018-2 administered in combination once daily for 9 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR1018-1
Description: Treatment group A : One tablet of BR1018-1 administered alone once daily for 9 days.~Treatment group C : One tablet each of BR1018-1 and BR1018-2 administered in combination once daily for 9 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR1018-1
Description: Treatment group A : One tablet of BR1018-1 administered alone once daily for 9 days.~Treatment group C : One tablet each of BR1018-1 and BR1018-2 administered in combination once daily for 9 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR1018-1
Description: Treatment group A : One tablet of BR1018-1 administered alone once daily for 9 days.~Treatment group C : One tablet each of BR1018-1 and BR1018-2 administered in combination once daily for 9 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR1018-1
Description: Treatment group A : One tablet of BR1018-1 administered alone once daily for 9 days.~Treatment group C : One tablet each of BR1018-1 and BR1018-2 administered in combination once daily for 9 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR1018-2
Description: Treatment group B : One tablet of BR1018-2 administered alone once daily for 9 days.~Treatment group C : One tablet each of BR1018-1 and BR1018-2 administered in combination once daily for 9 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR1018-2
Description: Treatment group B : One tablet of BR1018-2 administered alone once daily for 9 days.~Treatment group C : One tablet each of BR1018-1 and BR1018-2 administered in combination once daily for 9 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR1018-2
Description: Treatment group B : One tablet of BR1018-2 administered alone once daily for 9 days.~Treatment group C : One tablet each of BR1018-1 and BR1018-2 administered in combination once daily for 9 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR1018-2
Description: Treatment group B : One tablet of BR1018-2 administered alone once daily for 9 days.~Treatment group C : One tablet each of BR1018-1 and BR1018-2 administered in combination once daily for 9 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR1018-2
Description: Treatment group B : One tablet of BR1018-2 administered alone once daily for 9 days.~Treatment group C : One tablet each of BR1018-1 and BR1018-2 administered in combination once daily for 9 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR1018-2
Description: Treatment group B : One tablet of BR1018-2 administered alone once daily for 9 days.~Treatment group C : One tablet each of BR1018-1 and BR1018-2 administered in combination once daily for 9 days.